Implantation of a Jarvik 2000 left ventricular assist device as a bridge to eligibility for refractory heart failure with renal dysfunction

被引:5
|
作者
Kainuma, Satoshi [1 ]
Sakaguchi, Taichi [1 ]
Saito, Shunsuke [1 ]
Miyagawa, Shigeru [1 ]
Yoshikawa, Yasushi [1 ]
Yamauchi, Takashi [1 ]
Sakata, Yasushi [2 ]
Takahashi, Atsushi [3 ]
Uehata, Takuya [3 ]
Kuratani, Toru [1 ]
Sawa, Yoshiki [1 ]
机构
[1] Osaka Univ, Dept Cardiovasc Surg, Grad Sch Med, Suita, Osaka 5650871, Japan
[2] Osaka Univ, Dept Cardiol, Grad Sch Med, Suita, Osaka 5650871, Japan
[3] Osaka Univ, Dept Geriatr Med & Nephrol, Grad Sch Med, Suita, Osaka 5650871, Japan
关键词
Jarvik; 2000; Left ventricular assist device; Renal dysfunction; Heart transplantation; Cardiomyopathy; MECHANICAL CIRCULATORY SUPPORT; TRANSPLANTATION; EXPERIENCE; DISEASE;
D O I
10.1007/s10047-011-0602-8
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
A 55-year-old man, who previously underwent surgical ventricular restoration and mitral valve surgery, was referred to our department for management of refractory heart and multiple organ failure. At the time of admission to our hospital, he could not be registered as a candidate for heart transplantation because of severe renal failure with a serum creatinine level of 4.6 mg/dl. We considered that he was a marginal candidate for heart transplantation; thus, it was essential to understand the etiology of renal failure and estimate whether it was reversible. Cardiac catheterization revealed poor hemodynamic function with a systemic pressure of 107/60 mmHg, cardiac index of 2.5 l/min/m(2), and pulmonary artery pressure of 63/27 mmHg, despite intense medical treatment. Contrary to biochemical examination findings of blood, renal biopsy findings showed no significant glomerular abnormality. Furthermore, the severity of tubular atrophy and interstitial fibrosis in the cortex was mild. These pathological findings suggested that the renal dysfunction in this case was possibly attributable to a hemodynamic factor. His symptoms gradually deteriorated despite an increasing dose of inotropic support; thus, we planned implantation of a Jarvik 2000 axial-flow pump (Jarvik Heart Inc., New York, NY, USA) as a bridge to eligibility, and informed consent was obtained. Because of a tight adhesion on the anterior wall, we placed the device on the lateral wall of the left ventricle, making sure not to direct the pump at the septum. Postoperatively, the implantable left ventricular assist device provided relief from heart failure symptoms as well as recovery of renal function, with serum the creatinine level at 1.2 mg/dl, which allowed the patient to become an appropriate candidate for heart transplantation. At an 18-month follow-up examination, his status was uneventful, and he is now at home awaiting heart transplantation.
引用
收藏
页码:83 / 86
页数:4
相关论文
共 50 条
  • [1] Implantation of a Jarvik 2000 left ventricular assist device as a bridge to eligibility for refractory heart failure with renal dysfunction
    Satoshi Kainuma
    Taichi Sakaguchi
    Shunsuke Saito
    Shigeru Miyagawa
    Yasushi Yoshikawa
    Takashi Yamauchi
    Yasushi Sakata
    Atsushi Takahashi
    Takuya Uehata
    Toru Kuratani
    Yoshiki Sawa
    Journal of Artificial Organs, 2012, 15 : 83 - 86
  • [2] Use of Jarvik 2000 left ventricular assist device for treating acutely decompensated heart failure
    Anastasiadis, Kyriakos
    Antonitsis, Polychronis
    Papakonstantinou, Christos
    Westaby, Stephen
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2009, 35 (01) : 172 - 172
  • [3] Implantation of the Jarvik 2000 left-ventricular-assist-device: role of the maxillofacial surgeon
    Hohlweg-Majert, B
    Gutwald, R
    Siegenthaler, MP
    Schmelzeisen, R
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2005, 28 (02) : 337 - 339
  • [4] Implantation of the Jarvik 2000 left ventricular assist device without the use of cardiopulmonary bypass
    Frazier, OH
    ANNALS OF THORACIC SURGERY, 2003, 75 (03): : 1028 - 1030
  • [5] Stapled explant of the Jarvik 2000 left ventricular assist device
    Banbury, MK
    ANNALS OF THORACIC SURGERY, 2003, 75 (01): : 297 - 297
  • [6] Evolutionary Improvements in the Jarvik 2000 Left Ventricular Assist Device
    Selzman, Craig H.
    Koliopoulou, Antigone
    Glotzbach, Jason P.
    McKellar, Stephen H.
    ASAIO JOURNAL, 2018, 64 (06) : 827 - 830
  • [7] Implantation of the permanent Jarvik-2000 left-ventricular-assist-device: surgical technique
    Siegenthaler, MP
    Martin, J
    Frazier, OH
    Beyersdorf, F
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2002, 21 (03) : 546 - 548
  • [8] The Jarvik 2000 Left Ventricular Assist Device: Results of the United States Bridge to Transplant Trial
    Selzman, Craig H.
    Feller, Erika D.
    Walker, Jordan C.
    Sheridan, Brett C.
    Silvestry, Scott C.
    Daly, Richard C.
    Anyanwu, Ani C.
    Madigan, Dave
    Liu, Ping-Yu
    Frazier, O. Howard
    Jorde, Ulrich P.
    Griffith, Bartley P.
    ASAIO JOURNAL, 2023, 69 (02) : 174 - 182
  • [9] Less Invasive Surgical and Perfusion Technique for Implantation of the Jarvik 2000 Left Ventricular Assist Device
    Gerosa, Gino
    Gallo, Michele
    Tarzia, Vincenzo
    Di Gregorio, Guido
    Zanella, Fabio
    Bottio, Tomaso
    ANNALS OF THORACIC SURGERY, 2013, 96 (02): : 712 - 714
  • [10] Renal Failure Is Not a Contraindication to Left Ventricular Assist Device Implantation
    Kilic, A.
    Chen, C. W.
    Gaffey, A. C.
    Wald, J. W.
    Acker, M. A.
    Atluri, P.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (04): : S327 - S327